Insights & Events

In early 2010, Hollingsworth LLP began defending 32 Gadolinium-Based Contrast Agent (GBCA) personal injury cases pending in the Philadelphia Court of Common Pleas Complex Litigation Center on behalf of Firm clients General Electric Company and GE…

This industry coalition brief was filed on behalf of the U.S. Chamber of Commerce, American Chemistry Council, American Coatings Association, American Insurance Association, American Petroleum Institute, and National Association of Manufacturers.

On September 8, 2011, the Mississippi Supreme Court reversed a $7 million jury verdict against Sherwin-Williams in a lead paint case, holding that the trial court erred in failing to exclude plaintiffs’ expert causation witnesses. In…

After less than five hours of deliberation, a Brooklyn, New York federal jury on May 25, 2011, returned a verdict in favor of Novartis Pharmaceuticals Corporation in a seven-day trial involving Aredia® and Zometa®, bisphosphonate drugs…

This year, the Firm is a proud sponsor of the prestigious Sedona Conference® Working Group Series, a forum in which attorneys, jurists, and other stakeholders address some of the most challenging issues faced by our legal…

The United States District Court for the Middle District of Tennessee today granted Novartis Pharmaceutical Corporation’s motion for summary judgment in Foster v. Novartis Pharmaceuticals Corp., 3:08-0932 (M.D. Tenn.).  Mr. Foster alleged that his wife’s use…

After two hours of deliberation, a New Brunswick, New Jersey jury on October 6, 2010, returned a 7-2 verdict in favor of Novartis Pharmaceuticals Corporation in a ten-day trial involving Aredia and Zometa, bisphosphonate drugs given…

In September 2010, the U.S. Court of Appeals for the Sixth Circuit reversed a $20.5 million jury verdict in favor of a plaintiff in the welding fume litigation, holding that the district court had abused its…

  In one of very few reported cases enforcing a choice-of-law provision in the context of international employment agreements, the United States District Court for the Southern District of New York dismissed a wrongful death lawsuit…

The Hon. Sandra Mazer Moss, the judge presiding over the Gadolinium-Based Contrast Agent (GBCA) mass torts cases for the Philadelphia Court of Common Pleas, granted two more motions to dismiss cases on forum non conveniens grounds. …

On August 20, 2010, the first case set for trial in the In re Zometa®/Aredia® Litigation in Middlesex County, NJ, Judge Jessica Mayer granted summary judgment on plaintiffs’ direct-to-consumer (“DTC”) advertising claims against Novartis Pharmaceuticals Corporation…